Navigation Links
Brain Infarctions Found In Patients Suffering From Migraine

A new study shows people who suffer from migraine headaches may be at risk for brain // lesions and infarctions, which are areas of the brain where the tissue has died.

Researchers studied nearly 400 randomly selected adults, ages 30 to 60. They grouped the patients into categories of having migraines with visual difficulties and having migraines with no visual difficulties. A control group was also included in the study. Participants had a brain magnetic resonance imaging, blood samples drawn, and a physical and neurological examination. Their examinations were conducted during migraine-free periods.

Researchers did not find a significant difference between patients with migraines and the control groups in overall infarct presence. However, migraine patients did have a higher presence of infarcts in the cerebellar region, the area responsible for the regulation of voluntary movement and the maintenance of posture and balance.

Overall, patients with migraines and visual difficulties who had more than one attack per month were at the highest risk for infarcts and were 13 times more at risk than the control group. The risk was also greater for migraine patients with no visual difficulties.In the battle of the sexes, women with migraines were twice as likely to have white matter lesions than the controls. Male controls and patients with migraines did not differ in the number of lesions.

Thus researchers conclude that based on the current evidence, further study into the possible etiologic mechanisms of brain lesions in migraine patients is required as they feel this will not only provide important clues about the pathophysiology of migraine but also contribute to management guidelines for migraine.
'"/>




Page: 1

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Brain death – How to cope with it
3. “Brain fingerprinting”- The new lie detectr
4. Nasal Spray Could Take Drugs Direct to Brain.
5. Virus Combats Brain Tumour
6. Nasal Spray Could Take Drugs Directly to Brain
7. Control of anger disorder connected to Brain Dysfunction
8. High Levels of Protein Linked to Brain Shrinkage
9. Brain damage affects artistic skill
10. Brain cells protected by new compounds
11. Brain changes observed in people with sleep apnoea
Post Your Comments:
Other Medicine News:Health News:Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting 2Health News:Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting 3Health News:Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting 4Health News:Positive Results From Peregrine Pharmaceuticals' Bavituximab Phase l HCV Trial Presented at AASLD Meeting 5Health News:Crdentia Announces Appointment of Tim Jones to Senior Management Team 2Health News:Crdentia Announces Appointment of Tim Jones to Senior Management Team 3Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 2Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 3Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 4Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 5Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 6Health News:2007 America's Health Rankings(TM) Show a Decline in the Overall Health of the Nation 7Health News:ADVENTRX Pharmaceuticals to Present at the 13th Annual BIO-Europe Partnering Conference 2Health News:Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses 2Health News:Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses 3Health News:Boston Scientific Announces Sale of Cardiac Surgery and Vascular Surgery Businesses 4Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 2Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 3Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 4Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 5Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 6Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 7Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 8Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 9Health News:EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results 10
Breaking Medicine Technology:Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 2Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 3Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 4Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 5Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 6Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 7Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 8Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP 9Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 2ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 3ThermoGenesis Announces Agreement for Adipose Tissue Clinical Program 4ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 1ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 2ACCU CHEK 28R 29 Partners With MYLEstone Health to Enhance iPhone App Glucose Buddy and Web Site glucosebuddy com 61955 3Victory Pharma Inc Announces Launch of NAPRELAN 28R 29 Dose Card 61950 1Victory Pharma Inc Announces Launch of NAPRELAN 28R 29 Dose Card 61950 2Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 1Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 2Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 3Jubilant Organosys UAB and Southern Research Enter Into Drug Discovery Joint Venture 6469 4